Register Login

Abiopharma

  • Home
  • About
  • Newsroom
    • News
    • Company List
  • Events
  • Automated Tools
  • Contact

News list

ACTAVIS ELIZABETH

  • FDA Approval
  • Dec. 19, 2024, 09:46 UTC
  • 57
  • 0 comments

FDA approve GABAPENTIN

Comment Full text

IMPAX LABS INC

  • FDA Approval
  • Dec. 19, 2024, 09:46 UTC
  • 58
  • 0 comments

FDA approve DEXMETHYLPHENIDATE HYDROCHLORIDE

Comment Full text

ALKEM LABS LTD

  • FDA Approval
  • Dec. 19, 2024, 09:46 UTC
  • 56
  • 0 comments

FDA approve GABAPENTIN

Comment Full text

FDC LTD

  • FDA Approval
  • Dec. 19, 2024, 09:46 UTC
  • 55
  • 0 comments

FDA approve CEFIXIME

Comment Full text

BARR

  • FDA Approval
  • Dec. 19, 2024, 09:46 UTC
  • 70
  • 0 comments

FDA approve LANTHANUM CARBONATE

Comment Full text

RK PHARMA

  • FDA Approval
  • Dec. 19, 2024, 05:09 UTC
  • 60
  • 0 comments

FDA approve METHYLENE BLUE

Comment Full text

SPECGX LLC

  • FDA Approval
  • Dec. 19, 2024, 05:09 UTC
  • 67
  • 0 comments

FDA approve LISDEXAMFETAMINE DIMESYLATE

Comment Full text

NOVEL LABS INC

  • FDA Approval
  • Dec. 18, 2024, 09:43 UTC
  • 55
  • 0 comments

FDA approve DIAZEPAM

Comment Full text

MYLAN SPECIALITY LP

  • FDA Approval
  • Dec. 18, 2024, 09:43 UTC
  • 55
  • 0 comments

FDA approve AZELASTINE HYDROCHLORIDE; FLUTICASONE PROPIONATE

Comment Full text

MSN

  • FDA Approval
  • Dec. 18, 2024, 09:43 UTC
  • 52
  • 0 comments

FDA approve DEFERASIROX

Comment Full text
  • Previous
  • 227
  • 228
  • 229
  • 230
  • 231
  • Next

Search

News categories

  • Technical Exchange News(10600)
  • Event(2007)
  • SEC News(184713)
  • FDA Approval(9847)
  • Company Report(721)
  • Business News(122397)
Market reaction

© Copyright Abiopharma. All Rights Reserved
Designed by Alexey Vershinin